Previous research has also discovered that lncRNA ANRIL splicing, which is dependent on the m6A methylation of ANRIL, is how SRSF3 gene expression desensitizes tumor cells in the pancreas to the chemotherapy medication gemcitabine (Wang et al., 2022a). Here, CDKN2B-AS1 is linked to neoplasm.